Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats

被引:28
作者
Chang, KC
Hsu, KL
Tseng, CD
Lin, YD
Cho, YL
Tseng, YZ
机构
[1] Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Feng Chia Univ, Dept Automat Control Engn, Taichung 40724, Taiwan
关键词
advanced glycation endproducts; aminoguanidine; aortic input impedance; streptozotocin-diabetic rats; pulse wave reflection;
D O I
10.1038/sj.bjp.0706684
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The formation of advanced glycation endproducts (AGEs) on collagen within the arterial wall may be responsible for the development of diabetic vascular injury. This study was to examine the role of aminoguanidine (AG), an inhibitor of AGEs formation, in the prevention of arterial stiffening and cardiac hypertrophy in streptozotocin (STZ) induced diabetes in rats. 2 Diabetes was induced in animals by a single tail vein injection with 65 mg kg(-1) STZ. After confirmation of the development of hyperglycemia (2 days later), rats were treated for 8 weeks with AG (daily peritoneal injections of 50 mg kg(-1)) and compared with the age-matched untreated diabetic controls. 3 After exposure to AG, the STZ-diabetic rats showed no alterations in cardiac output, aortic pressure profiles, total peripheral resistance, and aortic characteristic impedance. 4 By contrast, treatment of this experimental diabetes with AG resulted in a significant increase in wave transit time (tau), from 20.4 +/- 0.6 to 24.7 +/- 0.5 ms (P < 0.05) and a decrease in wave reflection factor (R-f), from 0.78 +/- 0.04 to 0.53 +/- 0.02 (P < 0.05). The decreased R-f associated with the increased tau suggest that AG may retard the diabetes-induced augmentation in systolic load of the left ventricle coupled to its arterial system. 5 Meanwhile, the diminished ratio of left ventricular weight to body weight suggests that prevention of the diabetes-related cardiac hypertrophy by AG may correspond to the drug-induced decline in aortic stiffening. 6 Glycation-derived modification on aortic collagen was also found to be enhanced in rats with diabetes (+ 65.3%, P < 0.05) and the advanced glycation process was retarded by AG treatment. 7 We conclude that long-term administration of AG to the STZ-treated rats imparts significant protection against the diabetes-derived deterioration in vascular dynamics, at least partly through inhibition of the AGEs accumulation on collagen in the arterial wall.
引用
收藏
页码:944 / 950
页数:7
相关论文
共 46 条
[1]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[2]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[3]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[4]   AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING [J].
BROWNLEE, M ;
VLASSARA, H ;
KOONEY, A ;
ULRICH, P ;
CERAMI, A .
SCIENCE, 1986, 232 (4758) :1629-1632
[5]  
BROWNLEE N, 1988, NEW ENGL J MED, V318, P1315
[6]   Lipid and lipoprotein modification by advanced glycosylation end-products: Role in atherosclerosis [J].
Bucala, R .
EXPERIMENTAL PHYSIOLOGY, 1997, 82 (02) :327-337
[7]   Effects of diabetes and gender on mechanical properties of the arterial system in rats: Aortic impedance analysis [J].
Chang, KC ;
Hsu, KL ;
Tseng, YZ .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (01) :70-78
[8]   Impaired vascular dynamics in normotensive diabetic rats induced by streptozotocin: Tapered T-tube model analysis [J].
Chang, KC ;
Chen, TJ ;
Peng, YI ;
Li, TH ;
Tseng, YZ .
JOURNAL OF THEORETICAL BIOLOGY, 2000, 204 (03) :371-380
[9]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[10]   Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy [J].
Corman, B ;
Duriez, M ;
Poitevin, P ;
Heudes, D ;
Bruneval, P ;
Tedgui, A ;
Levy, BI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) :1301-1306